
Organometallics p. 2743 - 2749 (2006)
Update date:2022-08-04
Topics:
Schofer, Susan J.
Day, Michael W.
Henling, Lawrence M.
Labinger, Jay A.
Bercaw, John E.
Chromium-based ethylene trimerization catalyst precursors ((PNP OMe-d12)CrPh3 (4) and (PNPOMe-d 12)CrPh2Cl (7)) having a bis(diphenylphosphino)amine ligand (o-CD3OC6H4)2PN(CH 3)P(o-CD3OC6H4)2 ((PNPOMe-d12) = 1) have been prepared and characterized. A thioether analogue (o-CD3SC6H4) 2PN-(CH3)P(o-CD3SC6H 4)2 ((PNPSMe-d12) = 2) and its triphenylchromium complex (PNPSMe)CrPh3 (5) have also been synthesized. The solid-state structures of 4 and 7 display octahedral geometries with a κ3-(P,P,O) coordination of pNPOMe ligands having chromium-oxygen bond lengths of 2.29-2.44 A. Compound 5 differs, exhibiting (S,P,S)-κ3 coordination of the PNP SMe ligand. The deuteromethyl groups allow for 2H NMR characterization of these paramagnetic complexes in solution. Dynamic exchange processes occur in solution at room temperature to render all four of the methoxy or thioether groups equivalent on the 2H NMR time scale; two distinct coalescence processes are observed by variable-temperature 2H NMR spectroscopy for all compounds. The neutral species 4 and 7 react with ethylene (1 atm) by insertion into chromium-phenyl bonds with the release of styrene and ethylbenzene, but 1-hexene is not observed under these conditions. Activation of 4 by protonation and activation of 7 by halide abstraction in the presence of ethylene provide active trimerization catalysts that give turnover numbers for 1-hexene as high as 3000 mol 1- hexene·mol-1 Cr. These catalysts display comparable activity and selectivity for 1-hexene compared to the original BP system, where the catalyst is generated in situ from CrCl3(THF)3, 1, and MAO. Both the well-defined systems and the CrCl3(THF) 3/PNPOMe/MAO system provide catalysts that undergo an initiation period followed by an apparent first-order decomposition process. Activated complexes 4 and 7 initiate trimerization primarily through ethylene insertion into the chromium-phenyl bond, followed by β-hydrogen elimination and reductive elimination to give the active species, rather than via reductive elimination of biphenyl.
Huangshi Shennong Chemical Technology Co., Ltd
Contact:+86-714-3072290
Address:Eastern industrial park , Tieshan district , Huangshi city ,Hubei province , China
BAODING SINO-CHEM INDUSTRY CO.,LTD
Contact:0312-5956088
Address:NO.8 FUXING ROAD,CHINA
Shanghai Kefu Chemical Co.,Ltd.
Contact:+86-21-34616196
Address:Room601-602, Xuhui Business Building, No.168, Yude Road, Shanghai
Jiaxing Trustworthy Import And Export Co.,Ltd
Contact:+86-573-82030555
Address:Room 1202, Unit B, Charming plaza,No.1558 East Zhongshan Road , Jiaxing City, Zhejiang Province, China.
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Doi:10.1007/s10593-009-0169-y
(2008)Doi:10.1016/j.tetlet.2006.03.132
(2006)Doi:10.1016/S0040-4020(01)81539-8
(1990)Doi:10.1016/j.tet.2006.03.001
(2006)Doi:10.1039/b513293b
(2006)Doi:10.1021/ol8012155
(2008)